Literature DB >> 20231414

YopJ-promoted cytotoxicity and systemic colonization are associated with high levels of murine interleukin-18, gamma interferon, and neutrophils in a live vaccine model of Yersinia pseudotuberculosis infection.

Yue Zhang1, James B Bliska.   

Abstract

Several Yersinia species have been utilized as live attenuated vaccines to prime protective immunity against yersiniae and other pathogens. A type III secretion system effector known as YopJ in Y. pseudotuberculosis and Y. pestis and YopP in Y. enterocolitica has been shown to regulate host immune responses to live Yersinia vaccines. YopJ/P kills macrophages and dendritic cells, reduces their production of tumor necrosis factor alpha (TNF-alpha) and interleukin-12 (IL-12), and promotes systemic colonization in mouse models of intestinal Yersinia infection. Furthermore, YopP activity decreases antigen presentation by dendritic cells, and a yopP mutant of a live Y. enterocolitica carrier vaccine elicited effective priming of CD8 T cells to a heterologous antigen in mice. These results suggest that YopJ/P activity suppresses both innate and adaptive immune responses to live Yersinia vaccines. Here, a sublethal intragastric mouse infection model using wild-type and catalytically inactive yopJ mutant strains of Y. pseudotuberculosis was developed to further investigate how YopJ action impacts innate and adaptive immune responses to a live vaccine. Surprisingly, YopJ-promoted cytotoxicity and systemic colonization were associated with significant increases in neutrophils in spleens and the proinflammatory cytokines IL-18 and gamma interferon (IFN-gamma) in serum samples of mice vaccinated with Y. pseudotuberculosis. Secretion of IL-18 accompanied YopJ-mediated killing of macrophages infected ex vivo with Y. pseudotuberculosis, suggesting a mechanism by which this effector directly increases proinflammatory cytokine levels in vivo. Mice vaccinated with the wild-type strain or the yopJ mutant produced similar levels of antibodies to Y. pseudotuberculosis antigens and were equally resistant to lethal intravenous challenge with Y. pestis. The findings indicate that a proinflammatory, rather than anti-inflammatory, process accompanies YopJ-promoted cytotoxicity, leading to increased systemic colonization by Y. pseudotuberculosis and potentially enhancing adaptive immunity to a live vaccine.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20231414      PMCID: PMC2863517          DOI: 10.1128/IAI.00094-10

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  77 in total

Review 1.  The type III secretion injectisome.

Authors:  Guy R Cornelis
Journal:  Nat Rev Microbiol       Date:  2006-11       Impact factor: 60.633

Review 2.  Antimicrobial mechanisms of phagocytes and bacterial evasion strategies.

Authors:  Ronald S Flannagan; Gabriela Cosío; Sergio Grinstein
Journal:  Nat Rev Microbiol       Date:  2009-05       Impact factor: 60.633

3.  Yersinia pestis YopJ suppresses tumor necrosis factor alpha induction and contributes to apoptosis of immune cells in the lymph node but is not required for virulence in a rat model of bubonic plague.

Authors:  Nadine Lemaître; Florent Sebbane; Daniel Long; B Joseph Hinnebusch
Journal:  Infect Immun       Date:  2006-09       Impact factor: 3.441

4.  Yersinia enterocolitica Yop mutants as oral live carrier vaccines.

Authors:  Robert Leibiger; Katy Niedung; Gernot Geginat; Jürgen Heesemann; Konrad Trülzsch
Journal:  Vaccine       Date:  2008-12-02       Impact factor: 3.641

Review 5.  Patterns of pathogenesis: discrimination of pathogenic and nonpathogenic microbes by the innate immune system.

Authors:  Russell E Vance; Ralph R Isberg; Daniel A Portnoy
Journal:  Cell Host Microbe       Date:  2009-07-23       Impact factor: 21.023

6.  Type III secretion decreases bacterial and host survival following phagocytosis of Yersinia pseudotuberculosis by macrophages.

Authors:  Yue Zhang; James Murtha; Margaret A Roberts; Richard M Siegel; James B Bliska
Journal:  Infect Immun       Date:  2008-06-30       Impact factor: 3.441

7.  Role of IFN-gamma and IL-6 in a protective immune response to Yersinia enterocolitica in mice.

Authors:  Gianluca Matteoli; Edda Fahl; Philipp Warnke; Steffen Müller; Michael Bonin; Ingo B Autenrieth; Erwin Bohn
Journal:  BMC Microbiol       Date:  2008-09-19       Impact factor: 3.605

8.  Yersinia pseudotuberculosis disseminates directly from a replicating bacterial pool in the intestine.

Authors:  Penelope D Barnes; Molly A Bergman; Joan Mecsas; Ralph R Isberg
Journal:  J Exp Med       Date:  2006-06-05       Impact factor: 14.307

9.  Yersinia pestis endowed with increased cytotoxicity is avirulent in a bubonic plague model and induces rapid protection against pneumonic plague.

Authors:  Ayelet Zauberman; Avital Tidhar; Yinon Levy; Erez Bar-Haim; Gideon Halperin; Yehuda Flashner; Sara Cohen; Avigdor Shafferman; Emanuelle Mamroud
Journal:  PLoS One       Date:  2009-06-16       Impact factor: 3.240

10.  Reduced secretion of YopJ by Yersinia limits in vivo cell death but enhances bacterial virulence.

Authors:  Igor E Brodsky; Ruslan Medzhitov
Journal:  PLoS Pathog       Date:  2008-05-16       Impact factor: 6.823

View more
  18 in total

1.  Mathematical relationship between cytokine concentrations and pathogen levels during infection.

Authors:  Yue Zhang; James B Bliska
Journal:  Cytokine       Date:  2010-11-18       Impact factor: 3.861

2.  A protective epitope in type III effector YopE is a major CD8 T cell antigen during primary infection with Yersinia pseudotuberculosis.

Authors:  Yue Zhang; Patricio Mena; Galina Romanov; Jr-Shiuan Lin; Stephen T Smiley; James B Bliska
Journal:  Infect Immun       Date:  2011-11-07       Impact factor: 3.441

Review 3.  Yersinia type III effectors perturb host innate immune responses.

Authors:  Khavong Pha; Lorena Navarro
Journal:  World J Biol Chem       Date:  2016-02-26

4.  Anti-Pneumococcal Vaccine-Induced Cellular Immune Responses in Post-Traumatic Splenectomized Individuals.

Authors:  Djursun Karasartova; Umut Gazi; Ozgur Tosun; Ayse S Gureser; Ibrahim T Sahiner; Mete Dolapci; Aysegul T Ozkan
Journal:  J Clin Immunol       Date:  2017-05-09       Impact factor: 8.317

5.  LcrV delivered via type III secretion system of live attenuated Yersinia pseudotuberculosis enhances immunogenicity against pneumonic plague.

Authors:  Wei Sun; Shilpa Sanapala; Jeremy C Henderson; Shandiin Sam; Joseph Olinzock; M Stephen Trent; Roy Curtiss
Journal:  Infect Immun       Date:  2014-08-11       Impact factor: 3.441

6.  Effector CD8+ T cells are generated in response to an immunodominant epitope in type III effector YopE during primary Yersinia pseudotuberculosis infection.

Authors:  Yue Zhang; Patricio Mena; Galina Romanov; James B Bliska
Journal:  Infect Immun       Date:  2014-05-05       Impact factor: 3.441

7.  Caspase-8 and RIP kinases regulate bacteria-induced innate immune responses and cell death.

Authors:  Dan Weng; Robyn Marty-Roix; Sandhya Ganesan; Megan K Proulx; Gregory I Vladimer; William J Kaiser; Edward S Mocarski; Kimberly Pouliot; Francis Ka-Ming Chan; Michelle A Kelliher; Phillip A Harris; John Bertin; Peter J Gough; Dmitry M Shayakhmetov; Jon D Goguen; Katherine A Fitzgerald; Neal Silverman; Egil Lien
Journal:  Proc Natl Acad Sci U S A       Date:  2014-05-05       Impact factor: 11.205

8.  Type III secretion system-dependent translocation of ectopically expressed Yop effectors into macrophages by intracellular Yersinia pseudotuberculosis.

Authors:  Yue Zhang; Galina Romanov; James B Bliska
Journal:  Infect Immun       Date:  2011-08-15       Impact factor: 3.441

9.  Superantigenic Yersinia pseudotuberculosis induces the expression of granzymes and perforin by CD4+ T cells.

Authors:  Agathe Goubard; Caroline Loïez; Jun Abe; Caroline Fichel; Stéphanie Herwegh; Christelle Faveeuw; Rémi Porte; Delphine Cayet; Florent Sebbane; Sylvie Penet; Benoit Foligné; Pierre Desreumaux; Hirohisa Saito; Jean-Claude Sirard; Michel Simonet; Christophe Carnoy
Journal:  Infect Immun       Date:  2015-03-09       Impact factor: 3.441

10.  Uncovering an Important Role for YopJ in the Inhibition of Caspase-1 in Activated Macrophages and Promoting Yersinia pseudotuberculosis Virulence.

Authors:  Taylor J Schoberle; Lawton K Chung; Joseph B McPhee; Ben Bogin; James B Bliska
Journal:  Infect Immun       Date:  2016-03-24       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.